Skip to main content
Clinical Trials/RBR-22z3jy
RBR-22z3jy
Completed
Phase 2

Evaluation of the action of the treatment with platelet rich plasma in patients with Behçet Disease

niversidade Estadual de Campinas0 sitesJanuary 8, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Patients with Behçet disease
Sponsor
niversidade Estadual de Campinas
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Estadual de Campinas

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of Behçet disease according to established criteria according International Study Group for Behçet Disease (ISGBD); Minimum recurrence of three episodes of disease activity in the last year; presence of oral/genital ulcers, without corticosteroid use or at most with 10 mg daily (prednisone).

Exclusion Criteria

  • The exclusion criteria were: involvement of the central nervous system and/or ocular picture in activity, hematological or renal alterations; antecedent of Neoplasia in the last 5 year; use of corticosteroids in daily doses above 10 mg and use of anticoagulants.

Outcomes

Primary Outcomes

Not specified

Similar Trials